HCC Blood Test Vs Ultrasound
Blog HCC Blood Test Vs Ultrasound You have liver cirrhosis. Or hepatitis…
A simple blood test detects hepatocellular carcinoma at Stage I & II — when survival rates are 11× higher. No hospital visit. Results in 24 hours.
MoleculeDx at a Glance — Updated in real time
Live Data Feed
Liver cancer has no reliable early-warning signs. Most patients feel fine until the disease is already advanced. The tools to screen for it have been inaccessible, invasive, or simply absent — until now.
Liver cancer (HCC) is one of the fastest-growing cancers in the United States. However, most at-risk patients still receive no routine surveillance — because existing screening methods are expensive, require hospital imaging, and demand repeat visits that older adults often cannot complete.
As a result, 75% of American liver cancer patients are diagnosed when curative treatment is no longer possible. This outcome is not inevitable; it is simply a gap in access — and closing that gap is exactly what MoleculeDx was built to do.
Today, early liver cancer detection finally fits into a patient’s day, not the other way around. The MoleculeDx Fusion-detect™ blood test identifies hepatocellular carcinoma (HCC) at Stage I and Stage II — the window when survival rates are over 11× higher and treatment options are widest. Moreover, the entire process is at-home: no hospital visit, no biopsy, and certified results in 24 hours.
of liver cancers are detected at late stage — when survival drops from 34% to just 3%
UPMC Partnership: Walk-in testing now available at University of Pittsburgh Medical Center locations
Traditional liver cancer diagnosis depends on invasive procedures that carry real risks. In contrast, the MoleculeDx Fusion-detect™ test is simple, safe, and fully accessible from home — because early detection should never depend on whether a patient can travel to a hospital.
Fusion-detect™ outperforms every conventional liver cancer screening method currently available in the US.
Side-by-side accuracy metrics against the standard tests used in current clinical practice.
Although early liver cancer detection sounds clinical, the MoleculeDx process is anything but. From booking to certified result, every step has been designed for simplicity — especially for patients who find hospital visits exhausting, intimidating, or simply impossible.
Schedule your at-home blood draw in minutes at booking.moleculedx.com. Pick a time that works for you.
A certified partner (Portamedic or Travalab) visits your home and collects a standard blood sample — usually under 10 minutes.
Our Fusion-detect™ platform screens your sample for liver cancer fusion gene biomarkers with industry-leading accuracy.
Receive your certified report digitally. If further follow-up is needed, we connect you with a specialist immediately.
Certified phlebotomist within 48 hrs
Every barrier between you and early liver cancer detection has been removed. There are no hospital appointments to schedule, no waiting rooms to sit in, and no travel involved. Instead, a trained, certified phlebotomist comes directly to your door — usually within 48 hours of booking
Choose your date and 2-hour arrival window at booking.moleculedx.com — available 7 days a week, including evenings.
Our partners Portamedic and Travalab send nationally-certified phlebotomists to your door. The draw takes under 10 minutes.
Your sample is sealed and transported via cold-chain courier to our lab — maintaining integrity for the most accurate results.
A secure digital report lands in your inbox within 24 hours. No chasing down results — everything is clear and explained.
Fusion-detect™ is the proprietary genomic sequencing and AI analysis platform behind every MoleculeDx test. Specifically, it detects chromosomal fusion events — a hallmark of early-stage HCC — that conventional blood markers such as AFP completely miss.
Since 2014, the platform has moved through four distinct AI training generations, and each generation has measurably raised detection accuracy. Therefore, what began as a pattern-matching classifier in 2020 is, today, a clinically validated ensemble system trained on more than 50,000 patient samples.
Researchers identified 14 HCC-specific fusion gene events in circulating tumor DNA that appear up to 18 months before imaging-detectable tumors.
Initial ML classifier trained on 2,000 samples. Already outperformed AFP testing — but we knew we could go further.
A machine learning model trained on 2000+ annotated patient samples across multiple ethnic backgrounds for bias-free results.
Real-time ensemble AI with multi-biomarker fusion scoring, continuous learning pipeline, and <3% false positive rate. CLIA-certified and peer-review validated.
Both WHO and SEER data confirm that liver cancer (HCC) is one of the world’s fastest-growing cancers. Furthermore, in the absence of accessible early detection tools, this trajectory translates directly into more late-stage diagnoses and preventable deaths.
We’ve partnered with the best in US phlebotomy, clinical medicine, and health insurance to make testing seamless from booking to results.
One of America’s largest mobile health services networks — certified phlebotomists serving all 50 states, available 7 days a week for at-home blood draws.
Travalab’s mobile laboratory specialists provide concierge-level phlebotomy services, ensuring the highest sample quality and patient comfort from first contact.
University of Pittsburgh Medical Center — our exclusive clinical partner. UPMC patients and the public can walk in for testing at any UPMC facility.
Through our exclusive partnership with University of Pittsburgh Medical Center, you can walk into any UPMC facility today — no prior appointment required for testing referral.
No appointment needed at UPMC sites
UPMC oncologists review flagged results
Supported by UPMC clinical research program
Results flow directly into your UPMC medical record
A simple blood test could be the most important thing you do this year. Book online in 2 minutes and have a phlebotomist at your door within 48 hours.
Blog HCC Blood Test Vs Ultrasound You have liver cirrhosis. Or hepatitis…
Blog Liver Cancer Tumor Markers For decades, the search for liver cancer…
Blog Can Liver Cancer Be Detected By Blood Test? Here is a…
Moleculedx is a specialised molecular diagnostics platform focused on accessible, accurate cancer testing. We combine modern molecular assays with a simple online booking experience so patients, doctors, hospitals and partner labs can access cancer testing without friction.
Most cancer testing today is fragmented across hospitals, labs and clinics. Moleculedx unifies the journey — booking, sample collection, lab analysis and result delivery — under a single, transparent platform, with options for self-test, doctor referral, lab visit or home sample collection.
Moleculedx serves three groups: patients who want timely cancer testing, doctors and hospitals who need a reliable diagnostic partner, and partner laboratories that want to extend their reach through a digital platform.
Not necessarily. Moleculedx supports both self-tests and doctor-referred tests. If you choose self-test, you can complete the booking directly. If you prefer doctor referral, you can select a doctor from our list or add your own physician at the time of booking.
Visit moleculedx.com, choose your test, enter your details (name, date of birth, address, email, phone), select medical authorization (self-test or doctor referral), choose lab visit or home sample collection, and complete payment. Your booking is confirmed instantly.
Turnaround time depends on the specific test, but most reports are delivered within 5 to 10 working days from sample receipt. The exact turnaround is shown on each test’s detail page before you book.
Results are delivered in two ways — sent securely to your registered email and made available in your patient portal account, where you can download the full report and view your booking history at any time.
Yes. Moleculedx follows strict data privacy practices and applicable health data regulations. Your personal and medical information is encrypted in transit and at rest, and is only shared with authorized personnel and your designated doctor (if applicable).
Moleculedx services are currently available only in USA through our partner laboratory network and home-collection partners. Service availability for your address is confirmed during the booking flow.
Hospitals and labs can join the Moleculedx partner network and access dedicated portals to manage walk-in bookings, doctors and pricing. Visit the For Providers page or write to partners@moleculedx.com to begin the onboarding process.
© 2026 MoleculeDx Inc. All rights reserved.
This test is not a substitute for medical diagnosis. Consult your physician with all results.